"prostate tumor progression" trang 5 - tải miễn phí từ tailieunhanh
Differences in microRNA expression during tumor development in the transition and peripheral zones of the prostate

Differences in microRNA expression during tumor development in the transition and peripheral zones of the prostate
11    53    1
Hypofractionated helical intensity-modulated radiotherapy of the prostate bed after prostatectomy with or without the pelvic lymph nodes - the PRIAMOS trial

Hypofractionated helical intensity-modulated radiotherapy of the prostate bed after prostatectomy with or without the pelvic lymph nodes - the PRIAMOS trial
6    40    1
Quantitative bone SPECT/CT: High specificity for identification of prostate cancer bone metastases

Quantitative bone SPECT/CT: High specificity for identification of prostate cancer bone metastases
7    39    1
Gene expression analysis of human prostate cell lines with and without tumor metastasis suppressor CD82

Gene expression analysis of human prostate cell lines with and without tumor metastasis suppressor CD82
17    39    1
Metagenomic and metatranscriptomic analysis of human prostate microbiota from patients with prostate cancer

Metagenomic and metatranscriptomic analysis of human prostate microbiota from patients with prostate cancer
8    26    1
Perceived barriers to the adoption of active surveillance in low-risk prostate cancer: A qualitative analysis of community and academic urologists

Perceived barriers to the adoption of active surveillance in low-risk prostate cancer: A qualitative analysis of community and academic urologists
12    39    1
Possible role of HPV/EBV coinfection in anoikis resistance and development in prostate cancer

Possible role of HPV/EBV coinfection in anoikis resistance and development in prostate cancer
19    54    1
Exploring the association between use of gonadotropin releasing hormones agonists and prostate cancer diagnosis per se and diabetes control in men with type 2 diabetes mellitus: A nationwide, populationbased cohort study

Exploring the association between use of gonadotropin releasing hormones agonists and prostate cancer diagnosis per se and diabetes control in men with type 2 diabetes mellitus: A nationwide, populationbased cohort study
12    62    1
Corticosteroid switch from prednisone to dexamethasone in metastatic castrationresistant prostate cancer patients with biochemical progression on abiraterone acetate plus prednisone

Corticosteroid switch from prednisone to dexamethasone in metastatic castrationresistant prostate cancer patients with biochemical progression on abiraterone acetate plus prednisone
9    47    1
Sudden occurence of hypotension and bradycardia during greenlight laser transurethral resection of prostate: Case report of two cases

Sudden occurence of hypotension and bradycardia during greenlight laser transurethral resection of prostate: Case report of two cases
4    20    1
CKAP2L, a crucial target of miR-326, promotes prostate cancer progression

CKAP2L, a crucial target of miR-326, promotes prostate cancer progression
11    26    1
Phase III randomised controlled trial on PSMA PET/CT guided hypofractionated salvage prostate bed radiotherapy of biochemical failure after radical prostatectomy for prostate cancer (PERYTON-trial): Study protocol

Phase III randomised controlled trial on PSMA PET/CT guided hypofractionated salvage prostate bed radiotherapy of biochemical failure after radical prostatectomy for prostate cancer (PERYTON-trial): Study protocol
9    20    1
Androgen Deprivation therapy for Oligo-recurrent Prostate cancer in addition to radioTherapy (ADOPT): Study protocol for a randomised phase III trial

Androgen Deprivation therapy for Oligo-recurrent Prostate cancer in addition to radioTherapy (ADOPT): Study protocol for a randomised phase III trial
8    19    1
The ferroptosis-related long non-coding RNAs signature predicts biochemical recurrence and immune cell infiltration in prostate cancer

The ferroptosis-related long non-coding RNAs signature predicts biochemical recurrence and immune cell infiltration in prostate cancer
14    24    1
Master's thesis of Applied Science (Medical and Health Physics): Improving high dose rate and pulsed dose rate prostate brachytherapy : alternative prostate definition and treatment delivery verification methods

Master's thesis of Applied Science (Medical and Health Physics): Improving high dose rate and pulsed dose rate prostate brachytherapy : alternative prostate definition and treatment delivery verification methods
121    15    1
Defining aggressive prostate cancer: A geospatial perspective

Defining aggressive prostate cancer: A geospatial perspective
11    1    1
ORC6, a novel prognostic biomarker, correlates with T regulatory cell infiltration in prostate adenocarcinoma: A pan-cancer analysis

ORC6, a novel prognostic biomarker, correlates with T regulatory cell infiltration in prostate adenocarcinoma: A pan-cancer analysis
16    1    1
A randomized phase II trial of MR-guided prostate stereotactic body radiotherapy administered in 5 or 2 fractions for localized prostate cancer (FORT)

A randomized phase II trial of MR-guided prostate stereotactic body radiotherapy administered in 5 or 2 fractions for localized prostate cancer (FORT)
11    7    1
Unveiling poly(rC)-binding protein 2 as the target protein for curcusone C against prostate cancer: Mechanism validation through click chemistry-activity based proteomics profiling approach

Unveiling poly(rC)-binding protein 2 as the target protein for curcusone C against prostate cancer: Mechanism validation through click chemistry-activity based proteomics profiling approach
14    8    1
PRState: Incorporating genetic ancestry in prostate cancer risk scores for men of African ancestry

PRState: Incorporating genetic ancestry in prostate cancer risk scores for men of African ancestry
11    8    1